Purchases and Sales Made in Q4 2023 in Recursion Pharmaceuticals, Inc. (RXRX)
This table provides information about the institutional ownership of Recursion Pharmaceuticals, Inc. (RXRX) during Q4 2023. The information is specifically focused on institutions that hold shares of RECURSION PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
SELL
|
- |
-61.2K- 2.62% |
$311K - $660K
|
2.27M
$14.1M
|
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
SELL
|
- |
-65.7K- 13.95% |
$334K - $708K
|
405K
$2.5M
|
|
|
Feb 13, 2024
Q4 2023
|
Diametric Capital, LP
Boston, MA |
SELL
|
- |
-71.7K- 52.59% |
$365K - $774K
|
64.6K
$399K
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-193K- 78.78% |
$982K - $2.08M
|
52K
$321K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-267K- 87.96% |
$1.36M - $2.88M
|
36.5K
$226K
|
|
|
Feb 14, 2024
Q4 2023
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-269K- 31.54% |
$1.37M - $2.91M
|
585K
$3.62M
|
|
|
Jan 26, 2024
Q4 2023
|
Baillie Gifford & CO
|
SELL
|
- |
-372K- 1.51% |
$1.89M - $4.01M
|
24.2M
$149M
|
|
|
Feb 14, 2024
Q4 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-430K- 43.6% |
$2.19M - $4.64M
|
557K
$3.44M
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-574K- 60.12% |
$2.92M - $6.19M
|
381K
$2.35M
|
|
|
Feb 14, 2024
Q4 2023
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-2.27M- 71.44% |
$11.6M - $24.5M
|
908K
$5.61M
|